Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry - Takeaways - MDSpire

Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry

  • By

  • Duy Q. Pham

  • Darrah E. Sheehan

  • Kimball A. Sheehan

  • Konstantinos Katsos

  • Camilo E. Fadul

  • October 21, 2024

  • 0 min

Share

  • 1

    Brain metastases are the most common intracranial tumors in adults, with an estimated 70,000-100,000 cases annually in the U.S.

  • 2

    Stereotactic radiosurgery (SRS) is a minimally invasive treatment that effectively controls tumors and preserves cognitive function compared to whole-brain radiotherapy.

  • 3

    Quality of life (QOL) is a critical outcome for patients with brain metastases, influencing their treatment decisions and overall well-being.

  • 4

    The NeuroPoint Alliance SRS Registry collects data from patients undergoing SRS, providing insights into treatment outcomes and QOL changes.

  • 5

    The study utilizes EQ-5D scores to assess patient-reported health states, enabling a comprehensive evaluation of QOL before and after SRS.

Original Source(s)

Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry

  • by Duy Q. Pham, Darrah E. Sheehan, Kimball A. Sheehan, Konstantinos Katsos, Camilo E. Fadul

  • October 21, 2024

Related Content

Multiple ground-glass nodules after lobectomy for multiple primary lung cancer: a case report

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
Editorial: Epigenetic modulation in cancer